1999
DOI: 10.1006/abbi.1998.1071
|View full text |Cite
|
Sign up to set email alerts
|

Oxidation of Methionine Residues in Coagulation Factor VIIa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
24
0

Year Published

2007
2007
2015
2015

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(26 citation statements)
references
References 0 publications
2
24
0
Order By: Relevance
“…Complementary experiments confirmed this assumption and showed that these two peaks correspond to heavy chains bearing an oxidized methionine residue at position 298 and 306, respectively. This is in agreement with previously published data [28]. The other peaks originate from hydrolysis of HC either after Arg 290 or Arg 315 as deduced from accurate mass measurement (Table 1).…”
Section: Maldi-tofms Of Intact and N-deglycosylated Fviiasupporting
confidence: 92%
“…Complementary experiments confirmed this assumption and showed that these two peaks correspond to heavy chains bearing an oxidized methionine residue at position 298 and 306, respectively. This is in agreement with previously published data [28]. The other peaks originate from hydrolysis of HC either after Arg 290 or Arg 315 as deduced from accurate mass measurement (Table 1).…”
Section: Maldi-tofms Of Intact and N-deglycosylated Fviiasupporting
confidence: 92%
“…While the other two Met residues in hGH as well as the other five Met residues in hCS had dramatically different oxidation rates depending on their microenvironments. Different oxidation rates of Met residues in the same protein were also obtained for human parathyroid hormone [6], recombinant human granulocyte colony stimulating factor [7], recombinant interferon ␥ and recombinant tissue-type plasminogen activator [8], human cystatin C expressed in E. Coli [9], recombinant human leptin [10], recombinant coagulation factor exposed to H 2 O 2 [11] and wheat germ calmodulin [12]. Met oxidation is a concern for protein therapeutics due to the possible adverse effects such as in the case of recombinant human leptin [10], where decreased thermostability and a significant loss of in vitro bioactivity was observed when Met1 and Met69 were both oxidized.…”
Section: Introductionmentioning
confidence: 99%
“…[7][8][9][10] Met oxidation can have adverse effects on proteins, including decreased stability, 5,[11][12][13][14][15][16] and decreased biological activity. 5,8,12,[17][18][19][20] The immunoglobulin gamma (IgG) monoclonal antibody (mAb) has emerged as one of the most promising drug class in the biopharmaceutical industry. More than 20 antibody drug products have been approved by the FDA for human therapeutic use across many clinical settings.…”
Section: Introductionmentioning
confidence: 99%